Article (Published version) (1.4 MB) - Limited access to UNIGE
Other version: http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6TGX-5223Y1K-4-1&_cdi=5266&_user=9565874&_pii=S0731708511000...
Quality control of pharmaceutical formulations containing cisplatin, carboplatin, and oxaliplatin by micellar and microemulsion electrokinetic chromatography (MEKC, MEEKC)
|Published in||Journal of pharmaceutical and biomedical analysis. 2011, vol. 55, no. 2, p. 253-258|
|Abstract||A micellar electrokinetic chromatography (MEKC) method was developed for the determination of cisplatin, carboplatin, and oxaliplatin in pharmaceutical formulations. The background electrolyte consisted of a phosphate buffer (pH 7.0; 25mM) with sodium dodecyl sulfate (80mM). The applied voltage was 30kV and the sample injection was performed in the hydrodynamic mode. All analyses were carried out in a fused silica capillary with an internal diameter of 50μm and a total length of 64.5cm. The detection of target compounds was performed at 200nm. Under these conditions, a complete separation of cisplatin, carboplatin and oxaliplatin was achieved in less than 10min. The MEKC-UV method was validated and trueness values between 99.7% and 100.8% were obtained with repeatability and intermediate precision values of 0.7-1.4% and 1.1-1.7%, respectively for the three drugs. This method was found appropriate for controlling pharmaceutical formulations containing platinum complexes and successfully applied in quality control at the Geneva University Hospitals.|
|Keywords||Anticancer drugs — Capillary electrophoresis — Platinum drugs — Micellar electrokinetic chromatography (MEKC) — Quality control — Validation|